Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Early Phase 1
1(33.3%)
Phase 3
1(33.3%)
Phase 1
1(33.3%)
3Total
Early Phase 1(1)
Phase 3(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07548411Phase 1Active Not Recruiting

To Evaluate the Safety and Efficacy of GS1191-0445 Injection in the Treatment of Severe Hemophilia A

Role: lead

NCT07318909Early Phase 1Not Yet Recruiting

To Evaluate the Safety and Efficacy of GS1168 Injection in Adult Phenylketonuria

Role: lead

NCT06833983Phase 3Recruiting

To Evaluate the Clinical Study of GS1191-0445 Injection in the Treatment of Hemophilia A

Role: lead

All 3 trials loaded